August 21, 2025 | DoubleTree Dallas Near the Galleria
11:30-1:30 CT
Advancements in cell and gene therapy are revolutionizing healthcare, offering groundbreaking precision medicine solutions for complex and rare diseases. This luncheon will explore the latest innovations in cell and gene therapies, their impact on patient outcomes, and the strategies organizations can implement to integrate these cutting-edge treatments into healthcare benefits and coverage.
Join industry experts as they discuss the evolving landscape, regulatory considerations, cost implications, and real-world case studies showcasing the transformative potential of these therapies. This session is ideal for HR and benefits professionals, healthcare leaders, and policymakers seeking to stay ahead in the evolving field of precision medicine.
Key Discussion Topics:
Speakers:
***********************
Pending approval for 2.0 Hours of SHRM and HRCI CE
Sponsored by: